Testis cancer incidence in US continue to rise
Friday, 10 May 2013- The incidence of testicular cancer continued its puzzling rise through the end of the last decade, according to a study reported here.
Caucasian men continued to lead the rise with an incidence of 8.6 cases...
Risk factors for chronic kidney disease after chemotherapy for testis cancer
Friday, 7 December 2012- H. Inai and colleagues conducted a study to examine the patterns of and risk factors for deterioration of renal function after chemotherapy in metastatic testicular cancer survivors using the estimated...
Boys with undescended testes may have higher testis cancer risk
Monday, 3 December 2012- Boys whose testes have not descended have three times the risk for the later development of testicular cancer, a meta-analysis suggested. In an analysis of data from 12 studies published between 1980...
4th EMUC: international, multidisciplinary approach are key issues in treating penile and testis cancers
Saturday, 17 November 2012- Combined international efforts in both clinical and basic research are crucial to achieve significant breakthroughs in treating testis cancer, a disease which has seen increasing prevalence rates in...
Marijuana use linked to higher testis cancer risk
Tuesday, 11 September 2012- Smoking marijuana is associated with an increased risk of testicular cancer, but cocaine use is linked to a lessening of that risk, researchers reported. In a case-control study, people who...
Predicting metastasized seminoma using gene expression
Friday, 20 January 2012- C. G. Ruf and colleagues conducted a study to evaluate the usefulness of gene expression profiling for predicting metastatic status in testicular seminoma at the time of first diagnosis compared with...
Chemo treatment for testicular cancer increases neurotoxicity
Tuesday, 3 January 2012- Long-term serum levels of residual platinum correlate with the severity of neurotoxicity five to 20 years after chemotherapy in testicular cancer (TC) survivors, even after adjusting for initial cisplatin...
3rd EMUC: testes cancer treatment in high-volume centres
Friday, 18 November 2011- The 3rd European Multidisciplinary Meeting on Urological Cancers dedicated several of its presentations to testicular cancer. The meeting took place last week in Barcelona, Spain.
In this section, the...
Investigating the muscular effects of antineoplastic agents in testis cancer patients
Wednesday, 3 August 29011- Standard treatment for patients with disseminated germ cell tumours is combination chemotherapy with bleomycin, etoposide and cisplatin (BEP). This treatment is highly effective, but the majority of...













